December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

121.80 -1.63 (-1.32%)
Official Closing Price Updated: 4:00 PM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,579,797
Open 123.29
Bid (Size) 121.00 (2)
Ask (Size) 124.86 (1)
Prev. Close 123.43
Today's Range 121.57 - 123.92
52wk Range 96.06 - 133.55
Shares Outstanding N/A
Dividend Yield 3.28%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is the Market Bullish or Bearish on Novartis AG?
 
Via Benzinga
United Therapeutics Dips As Bread-And-Butter Drug Comes Up Short
Shares of United Therapeutics slipped slightly Wednesday on light sales of its bread-and-butter drug, Tyvaso. 
Via Investor's Business Daily

Performance

YTD
+25.4%
+25.4%
1 Month
-1.9%
-1.9%
3 Month
+3.9%
+3.9%
6 Month
+7.4%
+7.4%
1 Year
+5.3%
+5.3%

More News

Read More
Novartis Slips As Generics Champ At Heart-Failure Drug In Mixed Third Quarter
Via Investor's Business Daily
Earnings Scheduled For October 28, 2025
Via Benzinga
Novartis Maintains Outlook Even As Generics Bite Into Profits
Via Benzinga
'Merger Monday' Makes Comeback As US M&A Tops $80 Billion In 24 Hours
Via Benzinga
Dyne Therapeutics Stock Soars After Rival Avidity Biosciences Gets Acquired By Novartis
Via Stocktwits
What to Expect from Novartis's Earnings
Via Benzinga
Is It Too Late To Buy Avidity Stock After Novartis Deal?
Via Talk Markets
Why Dyne Therapeutics Stock Crushed the Market on Monday
Via The Motley Fool
Wall Street Soars as Qualcomm Ignites the AI Race
Via Chartmill
Topics Artificial Intelligence Stocks
Why Avidity Biosciences Stock Blasted 42% Higher Today
Via The Motley Fool
Avidity Biosciences Soars After $72 Per Share Novartis Takeover
Via Benzinga
Qualcomm, Tesla, Intellia Therapeutics, Avidity Biosciences, Dyne Therapeutics: Stocks Making The Biggest Moves Today
Via Stocktwits
Topics Artificial Intelligence ETFs Government
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
Via Investor Brand Network
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
Via FinancialNewsMedia
Avidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal
Via Benzinga
Why Avidity Biosciences Stock Is Jumping Over 43% In Premarket Today
Via Stocktwits
Stock Market Today: Dow Jones, S&P 500 Futures Climb Ahead Of Busy Week On Wall Street—Novartis, Nucor, Waste Management In Focus
Via Benzinga
Topics Stocks
Why Avidity Biosciences Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment
Via MarketMinute
Jim Cramer: Time To 'Pull The Trigger' On Kratos, A 'Terrific' Stock
Via Benzinga
AI Revolutionizes Drug Discovery and Personalized Medicine: A New Era of Healthcare
Via TokenRing AI
Topics Animal Testing Artificial Intelligence
Novartis Cosentyx Trial Shows Efficacy In Patients With Stiff Joints And Muscle Pain
Via Benzinga
Novartis AG-Sponsored ADR (NYSE:NVS): A Pillar of Dividend Reliability and Financial Health
Via Chartmill

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 121.80
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 10/29/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.